Pharma’s New Normal: Engaging with HCPs in Uncertain Times
Chris Bojrab, MD, DFAPA, President of Indiana Health Group
Arun Divakaruni, PhD, Chief Science Officer at Avant Healthcare
Face-to-face interactions between pharmaceutical companies and HCPs ceased overnight in the face of the COVID-19 pandemic. Amid this crisis, we had to quickly adjust to a new norm of interpersonal relationships. Join Avant Healthcare for an enlightening conversation with Dr. Chris Bojrab, board-certified psychiatrist and Distinguished Fellow of the American Psychiatric Association, as we look ahead to the future. We’ll discuss how pharma can demonstrate empathy for HCPs navigating uncertain times while continuing to educate on important clinical data and new products.
- Discern strategies for pharma to adapt education and engagement with HCPs who are navigating periods of complexity or crisis
- Identify ways to provide HCPs value, even when standard engagement methods become inconvenient or irrelevant
- Learn how to develop effective medical education in the face of our “new norm,” due to COVID-19-related changes to the pharma/HCP relationship
About the Sponsors
Avant Healthcare is a medical and marketing communications agency that strategically partners with pharmaceutical and biotechnology clients to engage and educate healthcare providers. By reshaping medical education, Avant Healthcare helps change the beliefs of healthcare provider audiences.For more information please visit avanthc.com/.